KL2 awards support mentored research career development for clinical investigators who have recently completed professional training and who are commencing basic, translational and/or clinical research. KL2 candidates are provided with a rich career development experience in a multidisciplinary setting.

Institutional Career Development (KL2) Program
The New Jersey Alliance for Clinical and Translational Science (NJ ACTS) is soliciting applications for its Institutional Career Development (KL2) program. The second class of KL2 Scholars will be appointed starting July 1, 2021.


This is an important opportunity for early stage faculty to be able to devote 80% effort to their projects, receive research funding and have the support of the community.


RFA for Translational Scientists: an abbreviated description of the program with a full list of the eligibility requirements.
Program Description:a detailed overview of the NJ ACTS KL2 Program, including information on current KL2 Scholars and a listing of the KL2 Program’s Academy of Mentors.
NJ ACTS KL2 Scholar Application: a fillable pdf to be submitted with the other required application materials.
Proposal Guidance and Requirements: a listing of the required components of a KL2 Scholar application packet.
NJ ACTS Diversity and Re-entry Supplements for Junior Faculty

NJ ACTS Diversity and Re-entry Supplements for Junior Faculty (Instructor and Assistant Professor)

Program Information

The CTSA Program is announcing diversity and re-entry research supplements, to promote opportunities for diversity in health-related research and re-entry into biomedical and behavioral research careers. The goal of these supplements is to build the clinical and translational research workforce that is prepared to improve the quality, safety, efficiency and speed of clinical and translational science research nationally.

What Do Diversity and Re-entry Supplements Offer?

  • Diversity supplements for junior faculty provide opportunity (salary, fringe benefits, travel and limited supplies) to improve the diversity of the research workforce by recruiting and supporting eligible investigators from diverse backgrounds, including those from groups that have been shown to be underrepresented in health-related research.
  • Re-entry supplements provide opportunity (salary, fringe benefits, travel and limited supplies) to support individuals with high potential to re-enter an active research career after an interruption for family responsibilities or other qualifying circumstances.

Read the Full Document Here

Questions: Contact Tracey Sharp.

Prior KL2 Opportunities
KL2 Opportunity for Early Stage Investors – The NCCIH has issued a Notice of Special Interest [NOT-AT-20-010], which invites CTSA-funded Institutional Career Development (KL2) awardees to apply for an administrative supplement to fund one or more additional KL2 Scholars.
Letters of Intent due July 1,2020
NJ ACTS Early Stage Investor Opportunity